Literature DB >> 33232272

Influence of aging on deterioration of patients with COVID-19.

Limin Pang1, Yi Liu1, Maoze Shen2, Jujian Ye1, Ruirong Chen1, Zhien Lan1, Zhijian Wu3, Yang Guo4, Peidong Zhang1.   

Abstract

Aging is an important factor affecting the deterioration of patients with coronavirus disease 2019 (COVID-19). The aging and degeneration of various tissues and organs in the elderly lead to impaired organ function. Underlying conditions such as chronic lung disease, cardiovascular disease, and diabetes in aged patients are associated with higher mortality. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily interacts with the cell surface receptor angiotensin-converting enzyme (ACE) 2 and other accessory proteins such as 78 kDa glucose-regulated protein 78 (GRP78) and CD147. Thus, altered receptor signals in aging and chronic disease play a role in SARS-CoV-2 infection, and are associated with a higher risk of deterioration in different organs. In this review, after a brief introduction to the link between aging and receptors for SARS-CoV-2, we focus on the risk of deterioration in different organs of COVID-19 patients considering aging as the main factor. We further discuss the structural and/or physiological changes in the immune system and organs (lung, heart, kidney, vessels, nerve system), as well as those associated with diabetes, in aging patients, and speculate on the most likely mechanisms underlying the deterioration of COVID-19 patients.

Entities:  

Keywords:  ACE2; CD147; COVID-19; GRP78; aging

Year:  2020        PMID: 33232272     DOI: 10.18632/aging.202136

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  3 in total

1.  Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine.

Authors:  Zihong Liang; Yanbo Jia; Lizhen Zhao; Runxiu Zhu; Xuemei He; Bagen Tong; Fan Yang; Lixia Hao; Pengfei Cui; Jun Yuan
Journal:  Aging (Albany NY)       Date:  2021-10-05       Impact factor: 5.682

2.  Local and systemic responses to SARS-CoV-2 infection in children and adults.

Authors:  Masahiro Yoshida; Kaylee B Worlock; Ni Huang; Rik G H Lindeboom; Colin R Butler; Natsuhiko Kumasaka; Cecilia Dominguez Conde; Lira Mamanova; Liam Bolt; Laura Richardson; Krzysztof Polanski; Elo Madissoon; Josephine L Barnes; Jessica Allen-Hyttinen; Eliz Kilich; Brendan C Jones; Angus de Wilton; Anna Wilbrey-Clark; Waradon Sungnak; J Patrick Pett; Juliane Weller; Elena Prigmore; Henry Yung; Puja Mehta; Aarash Saleh; Anita Saigal; Vivian Chu; Jonathan M Cohen; Clare Cane; Aikaterini Iordanidou; Soichi Shibuya; Ann-Kathrin Reuschl; Iván T Herczeg; A Christine Argento; Richard G Wunderink; Sean B Smith; Taylor A Poor; Catherine A Gao; Jane E Dematte; Gary Reynolds; Muzlifah Haniffa; Georgina S Bowyer; Matthew Coates; Menna R Clatworthy; Fernando J Calero-Nieto; Berthold Göttgens; Christopher O'Callaghan; Neil J Sebire; Clare Jolly; Paolo De Coppi; Claire M Smith; Alexander V Misharin; Sam M Janes; Sarah A Teichmann; Marko Z Nikolić; Kerstin B Meyer
Journal:  Nature       Date:  2021-12-22       Impact factor: 69.504

Review 3.  Role of senescence in the chronic health consequences of COVID-19.

Authors:  Erin O Wissler Gerdes; Greg Vanichkachorn; Brandon P Verdoorn; Gregory J Hanson; Avni Y Joshi; M Hassan Murad; Stacey A Rizza; Ryan T Hurt; Tamar Tchkonia; James L Kirkland
Journal:  Transl Res       Date:  2021-10-22       Impact factor: 7.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.